MeSH term
Frequency | Condition_Probility | Mice | 28 | 0.0 |
Molecular Sequence Data | 32 | 0.0 |
Promoter Regions (Genetics) | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 32 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Trans-Activation (Genetics) | 7 | 0.0 |
Amino Acid Sequence | 14 | 0.0 |
Animals | 40 | 0.0 |
Base Sequence | 31 | 0.0 |
COS Cells | 6 | 0.0 |
DNA-Binding Proteins/*metabolism | 5 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Hela Cells | 5 | 0.0 |
Humans | 46 | 0.0 |
Mutation | 5 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
Protein Binding | 9 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 49 | 0.0 |
Transcription Factors/*metabolism | 6 | 0.0 |
Transfection | 9 | 0.0 |
Two-Hybrid System Techniques | 4 | 0.0 |
Alleles | 3 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*physiology | 2 | 5.0 |
Dimerization | 4 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Osteoclasts/*physiology | 3 | 15.0 |
Cells, Cultured | 3 | 0.0 |
DNA-Binding Proteins/*genetics | 11 | 0.0 |
Gene Expression Regulation | 6 | 0.0 |
Helix-Loop-Helix Motifs | 9 | 3.0 |
Transcription Factors/*genetics | 11 | 0.0 |
Cell Line | 8 | 0.0 |
DNA Primers | 5 | 0.0 |
Rats | 5 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
Binding Sites | 9 | 0.0 |
Carcinoma, Renal Cell/*genetics | 5 | 5.0 |
*Cell Cycle Proteins | 3 | 0.0 |
Cercopithecus aethiops | 2 | 0.0 |
DNA-Binding Proteins/genetics | 5 | 0.0 |
Gene Expression | 5 | 0.0 |
Kidney Neoplasms/*genetics | 5 | 2.0 |
*Neoplasm Proteins | 8 | 1.0 |
Proteins/*genetics/metabolism | 2 | 0.0 |
Transcription Factors/genetics | 7 | 0.0 |
*Translocation, Genetic | 7 | 0.0 |
*X Chromosome | 9 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 3 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Mice, Inbred Strains | 2 | 0.0 |
Phosphorylation | 3 | 0.0 |
Carrier Proteins/*genetics/metabolism | 2 | 0.0 |
*Symporters | 2 | 2.0 |
Transcription, Genetic/*physiology | 2 | 1.0 |
DNA-Binding Proteins/genetics/metabolism/*physiology | 2 | 3.0 |
Helix-Loop-Helix Motifs/genetics | 4 | 10.0 |
Leucine Zippers/genetics | 2 | 4.0 |
*Trans-Activation (Genetics) | 5 | 0.0 |
Transcription Factors/genetics/metabolism/*physiology | 2 | 3.0 |
Adolescent | 5 | 0.0 |
Adult | 8 | 0.0 |
Child | 3 | 0.0 |
Child, Preschool | 2 | 0.0 |
Female | 12 | 0.0 |
Male | 14 | 0.0 |
Carcinoma, Papillary/*genetics | 3 | 9.0 |
Chromosomes, Human, Pair 17 | 2 | 0.0 |
Gene Fusion | 4 | 4.0 |
Translocation, Genetic/*genetics | 2 | 0.0 |
X Chromosome | 2 | 0.0 |
DNA | 4 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 2 | 0.0 |
Gene Expression Regulation, Enzymologic/*physiology | 2 | 2.0 |
RNA, Messenger/genetics | 4 | 0.0 |
*Transcription Factors | 4 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 3 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Transcription Factors/*genetics/metabolism | 3 | 0.0 |
Transcription, Genetic | 8 | 0.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Blotting, Southern | 4 | 0.0 |
Chromosome Mapping | 10 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
X Chromosome/*genetics | 3 | 0.0 |
Drug Synergism | 2 | 0.0 |
Transcription, Genetic/*drug effects | 2 | 0.0 |
Transforming Growth Factor beta/*pharmacology | 2 | 0.0 |
3T3 Cells | 7 | 0.0 |
*Membrane Glycoproteins | 2 | 0.0 |
*Oxidoreductases | 2 | 2.0 |
Sequence Deletion | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 5 | 0.0 |
DNA/*metabolism | 3 | 0.0 |
Plasminogen Activator Inhibitor 1/*genetics | 3 | 8.0 |
*Promoter Regions (Genetics) | 5 | 0.0 |
Trans-Activators/*metabolism | 4 | 0.0 |
*Transcription, Genetic | 4 | 0.0 |
Cloning, Molecular | 7 | 0.0 |
Enhancer Elements (Genetics) | 3 | 0.0 |
*Helix-Loop-Helix Motifs | 7 | 7.0 |
Immunoglobulins, mu-Chain/*genetics | 2 | 22.0 |
*Leucine Zippers | 8 | 16.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Comparative Study | 6 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Exons | 3 | 0.0 |
Introns | 4 | 0.0 |
Signal Transduction | 2 | 0.0 |
Leucine Zippers | 8 | 4.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Nuclear Proteins/*genetics | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
*DNA-Binding Proteins | 3 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
Tissue Distribution | 3 | 0.0 |
Carcinoma, Renal Cell/*genetics/metabolism | 2 | 13.0 |
Chromosomes, Human, Pair 1 | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
B-Lymphocytes/*physiology | 3 | 2.0 |
Transcription Factors/genetics/*physiology | 2 | 1.0 |
*Enhancer Elements (Genetics) | 5 | 1.0 |
*Genes, Immunoglobulin | 2 | 1.0 |
Immunoglobulins, Heavy-Chain/*genetics | 3 | 2.0 |
Recombinant Fusion Proteins | 2 | 0.0 |
Cell-Free System | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Nucleic Acid Conformation | 2 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
Transcription Factors/chemistry/genetics/*metabolism | 2 | 1.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
Genetic Markers | 4 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
*Linkage (Genetics) | 3 | 0.0 |
DNA-Binding Proteins/chemistry/*metabolism | 2 | 1.0 |
Macromolecular Substances | 2 | 0.0 |
Transcription Factors/chemistry/*metabolism | 2 | 1.0 |
Linkage (Genetics) | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Plasmids | 3 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Protein Conformation | 2 | 0.0 |
Oncogene Proteins, Fusion/genetics | 2 | 2.0 |
